Want to see CH:MOVE full AI Analyst Report?
Medacta Group SA (MOVE) Stock Statistics & Valuation Metrics
Total Valuation
Medacta Group SA has a market cap or net worth of CHF 2.35B. The enterprise value is CHF 2.98B.
- Market Cap
- CHF 2.35B
- Enterprise Value
- CHF 2.98B
Share Statistics
Medacta Group SA has 20,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 20,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- 5.21%
Financial Efficiency
Medacta Group SA’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 11.91%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- 0.10
- Return on Invested Capital (ROIC)
- 11.91%
- Return on Capital Employed (ROCE)
- 0.17
- Revenue Per Employee
- 302.80K
- Profits Per Employee
- 42.29K
- Employee Count
- 2,273
- Asset Turnover
- 0.75
- Inventory Turnover
- 0.89
Valuation Ratios
The current PE Ratio of Medacta Group SA is 32.84. Medacta Group SA’s PEG ratio is -1.80.
- PE Ratio
- 32.84
- PS Ratio
- 3.61
- PB Ratio
- 5.25
- Price to FCF
- -1378.05
- Price to Operating Cash Flow
- 18.92
- PEG Ratio
- -1.80
Income Statement
In the last 12 months, Medacta Group SA had revenue of 688.27M and earned 96.12M in profits. Earnings per share was 4.81.
- Revenue
- 688.27M
- Gross Profit
- 441.40M
- Operating Income
- 115.65M
- Pretax Income
- 116.05M
- Net Income
- 96.12M
- EBITDA
- 190.07M
- Earnings Per Share (EPS)
- 4.81
Cash Flow
In the last 12 months, operating cash flow was 134.56M and capital expenditures -136.41M, giving a free cash flow of -1.85M billion.
- Operating Cash Flow
- 134.56M
- Free Cash Flow
- -1.85M
- Free Cash Flow per Share
- -0.09
Dividends & Yields
Medacta Group SA pays an annual dividend of CHF 1.10, resulting in a dividend yield of 0.94%
- Dividend Per Share
- CHF 1.10
- Dividend Yield
- 0.94%
- Payout Ratio
- 24.47%
- Free Cash Flow Yield
- -0.07%
- Earnings Yield
- 3.03%
Stock Price Statistics
- Beta
- 0.79
- 52-Week Price Change
- -20.43%
- 50-Day Moving Average
- 117.88
- 200-Day Moving Average
- 137.78
- Relative Strength Index (RSI)
- 51.09
- Average Volume (3m)
- 29.95K
Important Dates
Medacta Group SA upcoming earnings date is Mar 12, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 09, 2026
- Next Earnings Date
- Mar 12, 2027
- Ex-Dividend Date
- May 07, 2026
Financial Position
Medacta Group SA as a current ratio of 2.08, with Debt / Equity ratio of 57.55%
- Current Ratio
- 2.08
- Quick Ratio
- 0.80
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- 1.21
- Interest Coverage Ratio
- 16.87
Taxes
In the past 12 months, Medacta Group SA has paid 19.96M in taxes.
- Income Tax
- 19.96M
- Effective Tax Rate
- 0.17
Enterprise Valuation
Medacta Group SA EV to EBITDA ratio is 14.81, with an EV/FCF ratio of -1532.44.
- EV to Sales
- 4.01
- EV to EBITDA
- 14.81
- EV to Free Cash Flow
- -1532.44
- EV to Operating Cash Flow
- 21.06
Balance Sheet
Medacta Group SA has CHF 36.10M in cash and marketable securities with CHF 321.58M in debt, giving a net cash position of -CHF 285.48M billion.
- Cash & Marketable Securities
- CHF 36.10M
- Total Debt
- CHF 321.58M
- Net Cash
- -CHF 285.48M
- Net Cash Per Share
- -CHF 14.27
- Tangible Book Value Per Share
- CHF 20.93
Margins
Gross margin is 65.52%, with operating margin of 13.54%, and net profit margin of 10.92%.
- Gross Margin
- 65.52%
- Operating Margin
- 13.54%
- Pretax Margin
- 13.84%
- Net Profit Margin
- 10.92%
- EBITDA Margin
- 27.08%
- EBIT Margin
- 15.44%
Analyst Forecast
The average price target for Medacta Group SA is CHF 150.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- CHF 150.50
- Price Target Upside
- 27.98% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 7.51%
- EPS Growth Forecast
- -20.13%
Scores
- Smart Score
- ―
- AI Score
- 64